-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/hispanichealth/2014nhqdr-hispanichealth-pt3.pptx
September 19, 2015 - most effective prevention and treatment practices for the leading causes of mortality, starting with cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2022qdr-appendix-combined.pdf
October 25, 2022 - • From 2000 to 2020, 83% of cancer measures, 14% of cardiovascular disease measures, 20%
of chronic … • From 2000 to 2020, 14% of cardiovascular disease measures, 14% of diabetes measures, and
60% of mental
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/hispanichealth/2014nhqdr-hispanichealth-pt3.pdf
June 01, 2014 - most effective prevention and treatment practices for the leading causes of
mortality, starting with cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-131-fullreport.pdf
April 05, 2017 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-145-fullreport.pdf
July 01, 2016 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-fullreport.pdf
December 17, 2019 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
February 02, 2012 - Cardiovascular monitor-
ing and stimulant drugs for attention-
deficit/hyperactivity disorder.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
January 01, 2014 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-136-fullreport.pdf
July 01, 2018 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-fullreport.pdf
January 01, 2020 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
February 02, 2012 - Cardiovascular monitor
ing and stimulant drugs for attention
deficit/hyperactivity disorder.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-205-fullreport.pdf
January 01, 2014 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-146-fullreport.pdf
January 01, 2020 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/ncepcr/reports/primary-care-research/results.html
January 01, 2024 - approach to develop logic, computer code, and a cloud-based platform to disseminate CDS for hypertension, cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/diagnostic/resources/issue-briefs/dx-safety-older-adults.pdf
January 17, 2024 - function reserve
and an increased prevalence of common comorbid conditions, including hypertension, cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0120-fullreport.pdf
May 01, 2018 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-fullreport.pdf
October 01, 2019 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
November 01, 2019 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-fullreport.pdf
September 01, 2019 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-fullreport.pdf
April 01, 2018 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular